These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24380239)
1. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia. Jakovski K; Nestorovska AK; Labacevski N; Dimovski AJ Pharmazie; 2013 Nov; 68(11):893-8. PubMed ID: 24380239 [TBL] [Abstract][Full Text] [Related]
2. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309 [TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population. Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145 [TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population. Zand N; Tajik N; Moghaddam AS; Milanian I Clin Exp Pharmacol Physiol; 2007; 34(1-2):102-5. PubMed ID: 17201743 [TBL] [Abstract][Full Text] [Related]
5. CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population. Jose R; Chandrasekaran A; Sam SS; Gerard N; Chanolean S; Abraham BK; Satyanarayanamoorthy K; Peter A; Rajagopal K Fundam Clin Pharmacol; 2005 Feb; 19(1):101-5. PubMed ID: 15660966 [TBL] [Abstract][Full Text] [Related]
6. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population. Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905 [TBL] [Abstract][Full Text] [Related]
7. Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population. Afilal D; Basselam MA; Brakez Z; Chouham S; Brehm A; Izaabel EH Genet Test Mol Biomarkers; 2017 May; 21(5):298-304. PubMed ID: 28282224 [TBL] [Abstract][Full Text] [Related]
8. Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population. Hamdy SI; Hiratsuka M; Narahara K; El-Enany M; Moursi N; Ahmed MS; Mizugaki M Br J Clin Pharmacol; 2002 Jun; 53(6):596-603. PubMed ID: 12047484 [TBL] [Abstract][Full Text] [Related]
9. Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran. Azarpira N; Namazi S; Hendijani F; Banan M; Darai M Pharmacol Rep; 2010; 62(4):740-6. PubMed ID: 20885015 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China. Yang ZF; Cui HW; Hasi T; Jia SQ; Gong ML; Su XL Genet Mol Res; 2010 Sep; 9(3):1844-51. PubMed ID: 20845310 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population. Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181 [TBL] [Abstract][Full Text] [Related]
12. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population. Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study. Bravo-Villalta HV; Yamamoto K; Nakamura K; Bayá A; Okada Y; Horiuchi R Eur J Clin Pharmacol; 2005 May; 61(3):179-84. PubMed ID: 15776277 [TBL] [Abstract][Full Text] [Related]
14. Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran). Hashemi-Soteh SM; Shahabi-Majd N; Gholizadeh AR; Shiran MR Genet Test Mol Biomarkers; 2012 Jul; 16(7):817-21. PubMed ID: 22288731 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI). Pachkoria K; Lucena MI; Ruiz-Cabello F; Crespo E; Cabello MR; Andrade RJ; Br J Pharmacol; 2007 Mar; 150(6):808-15. PubMed ID: 17279092 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of five pharmacologically most important Vidović S; Škrbić R; Stojiljković MP; Vidović V; Bećarević J; Stoisavljević-Šatara S; Maksimović N Arh Hig Rada Toksikol; 2021 Jun; 72(3):129-134. PubMed ID: 34187105 [TBL] [Abstract][Full Text] [Related]
17. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294 [TBL] [Abstract][Full Text] [Related]
18. [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration]. Huang Y; Yang JF; Qi XL; Wang YQ; Wang WZ; Chen B Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1686-9. PubMed ID: 15569425 [TBL] [Abstract][Full Text] [Related]
19. Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations. Pedersen RS; Brasch-Andersen C; Sim SC; Bergmann TK; Halling J; Petersen MS; Weihe P; Edvardsen H; Kristensen VN; Brøsen K; Ingelman-Sundberg M Eur J Clin Pharmacol; 2010 Dec; 66(12):1199-205. PubMed ID: 20665013 [TBL] [Abstract][Full Text] [Related]
20. Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. Kudzi W; Dodoo AN; Mills JJ BMC Med Genet; 2009 Dec; 10():124. PubMed ID: 19954515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]